The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis

被引:16
|
作者
Yin, Juan [1 ]
Ji, Zhenhao [1 ]
Liang, Peifeng [1 ]
Wu, Qian [1 ]
Cui, Fuqiang [2 ]
Wang, Fuzhen [2 ]
Liang, Xiaofeng [2 ]
Zhuang, Guihua [1 ]
机构
[1] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710061, Shaanxi, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China
关键词
Hepatitis B vaccine; Dose; Newborn; Cost-effectiveness analysis; Quality-adjusted life-year; VIRUS INFECTION; NATURAL-HISTORY; MATHEMATICAL-MODEL; HEPATOCELLULAR-CARCINOMA; ECONOMIC BURDEN; CHILDREN; IMMUNIZATION; ADOLESCENTS; STRATEGIES; PROTECTION;
D O I
10.1016/j.vaccine.2015.05.082
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To identify whether Chinese current series of three 5 mu g doses for newborn hepatitis B vaccination should be replaced by the series of three 10 mu g doses. Methods: A cost-effectiveness analysis was conducted from the societal perspective based on the constructed decision tree-Markov model. Model parameters were estimated from published literatures, government documents and our surveys. The expected cost and effectiveness were compared between the 3-dose 5 mu g series (the 5 mu g strategy) and the 3-dose 10 mu g series (the 10 mu g strategy), and the incremental cost-effectiveness ratio (ICER, additional cost per quality-adjusted life-years gained) was calculated. Threshold values of the efficacy difference of the two series for the ICER=0, 1 and 3 times per capita gross domestic product were analyzed under different scenarios to understand whether the 10 mu g strategy should replace the 5 mu g strategy according to the recommendation of World Health Organization. Results: The 10 mu g strategy would be cost-saving compared with the 5 mu g strategy under the base-case scenario. Under keeping all the other parameters at the base-case values or further adjusting any one of them to the value most unfavorable to the 10 mu g strategy, as long as the efficacy of 3-dose 10 mu g series was slightly higher than that of 3-dose 5 mu g series, the 10 mu g strategy would be cost-effective, highly cost-effective, or even cost-saving. Even under the most pessimistic scenario, i.e. all the other parameters, but the discount rate, at the values most unfavorable to the 10 p.g strategy, the 10 p..g strategy would be cost-effective if the efficacy difference reached higher than 1.23 percentage point. Conclusion: For newborn hepatitis B vaccination in China, the 10 mu g strategy should be cost-effective, even more possibly highly cost-effective or cost-saving compared with the current 5 mu g strategy. The doses of 10 mu g should be considered to replace the doses of 5 mu g in newborn hepatitis B vaccination in China. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3731 / 3738
页数:8
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China
    Cui, Tingting
    Zhang, Xuefeng
    Wang, Qiang
    Yue, Na
    Bao, Changjun
    Jiang, Renjie
    Xu, Shilin
    Yuan, Zhaohu
    Qian, Yunke
    Chen, Liling
    Hang, Hui
    Zhang, Zhong
    Sun, Hongmin
    Jin, Hui
    HEPATOLOGY RESEARCH, 2024, 54 (02) : 142 - 150
  • [2] Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China
    Jia, Yuanxi
    Li, Li
    Cui, Fuqiang
    Zhang, Dongliang
    Zhang, Guomin
    Wang, Fuzhen
    Gong, Xiaohong
    Zheng, Hui
    Wu, Zhenhua
    Miao, Ning
    Sun, Xiaojin
    Zhang, Li
    Lv, Jingjing
    Yang, Feng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 2983 - 2991
  • [3] Cost-effectiveness analysis of pneumococcal vaccination for infants in China
    Maurer, Kristin A.
    Chen, Huey-Fen
    Wagner, Abram L.
    Hegde, Sonia T.
    Patel, Tejasi
    Boulton, Matthew L.
    Hutton, David W.
    VACCINE, 2016, 34 (50) : 6343 - 6349
  • [4] Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines:: A comparison of two doses (10 μg and 5 μg)
    Chiu, HH
    Huang, LM
    Lee, PI
    Safary, A
    Lee, CY
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) : 206 - 211
  • [5] Cost-effectiveness of seasonal influenza vaccination of children in China: a modeling analysis
    Wang, Qiang
    Jin, Huajie
    Yang, Liuqing
    Jin, Hui
    Lin, Leesa
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [6] RANDOMIZED COMPARISON OF 5 AND 10 MU-G DOSES OF 2 RECOMBINANT HEPATITIS-B VACCINES
    BRYAN, JP
    CRAIG, PG
    REYES, L
    HAKRE, S
    JARAMILLO, R
    HARLAN, H
    MACARTHY, P
    LEGTERS, LJ
    VACCINE, 1995, 13 (11) : 978 - 982
  • [7] Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination With Immunoglobin Treatment
    Chen, Solomon Chih-Cheng
    Toy, Mehlika
    Yeh, Jennifer M.
    Wang, Jung-Der
    Resch, Stephen
    PEDIATRICS, 2013, 131 (04) : E1135 - E1143
  • [8] Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China
    Hutton, David W.
    So, Samuel K.
    Brandeau, Margaret L.
    HEPATOLOGY, 2010, 51 (02) : 405 - 414
  • [9] Measles vaccination of young infants in China: A cost-effectiveness analysis
    Janusz, Cara Bess
    Wagner, Abram L.
    Masters, Nina B.
    Ding, Yaxing
    Zhang, Ying
    Hutton, David W.
    Boulton, Matthew L.
    VACCINE, 2020, 38 (29) : 4616 - 4624
  • [10] Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan
    Sorano, Sumire
    Procter, Simon R.
    Seale, Anna C.
    VACCINE: X, 2023, 14